肝细胞癌的危险因素：历史视角
Risk Factors for Hepatocellular Carcinoma: A Historical Perspective.
作者信息
Natarajan Yamini, El-Serag Hashem B
机构信息
Section of Gastroenterology and Hepatology Department of Medicine Michael E DeBakey VA Medical Center and Baylor College of Medicine Houston TX.
出版信息
Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):1-13. doi: 10.1002/cld.1042. eCollection 2021 Oct.
Abstract
Content available: Author Audio Recording.
摘要
内容提供
作者音频记录。
相似文献
1
Risk Factors for Hepatocellular Carcinoma: A Historical Perspective.肝细胞癌的危险因素：历史视角
Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):1-13. doi: 10.1002/cld.1042. eCollection 2021 Oct.
2
Hepatocellular Carcinoma in Mexico.墨西哥的肝细胞癌
Clin Liver Dis (Hoboken). 2022 Mar 10;19(2):73-77. doi: 10.1002/cld.1196. eCollection 2022 Feb.
3
Closing the disparity gap and optimizing advanced hepatocellular carcinoma care in the hispanic community.缩小西班牙裔社区的差距并优化晚期肝细胞癌的治疗
Clin Liver Dis (Hoboken). 2022 May 27;19(6):239-243. doi: 10.1002/cld.1213. eCollection 2022 Jun.
4
Emerging liquid biopsy techniques for early detection of hepatocellular carcinoma, prognostication, and disease monitoring.用于肝细胞癌早期检测、预后评估和疾病监测的新兴液体活检技术。
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):18-20. doi: 10.1002/cld.1232. eCollection 2022 Jul.
5
A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant.自发性细菌性腹膜炎的历史概述：从罕见到耐药
Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):63-75. doi: 10.1002/cld.1122. eCollection 2021 Oct.
6
Historical Aspects of Ascites and the Hepatorenal Syndrome.腹水与肝肾综合征的历史回顾
Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):14-27. doi: 10.1002/cld.1090. eCollection 2021 Oct.
7
The Patient Perspective on Telemedicine.患者对远程医疗的看法。
Clin Liver Dis (Hoboken). 2022 Jan 28;19(4):167-170. doi: 10.1002/cld.1188. eCollection 2022 Apr.
8
The challenges of ascites management: An Indian perspective.腹水管理的挑战：印度视角
Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):234-238. doi: 10.1002/cld.1209. eCollection 2022 Jun.
9
Effects of Historical Recording Technology on Vibrato in Modern-Day Opera Singers.历史录音技术对现代歌剧演唱者颤音的影响。
J Voice. 2022 Jul;36(4):464-478. doi: 10.1016/j.jvoice.2020.07.022. Epub 2020 Aug 18.
10
A historical review of jaundice: May the golden oriole live forever.黄疸的历史回顾：愿金莺永生。
Clin Liver Dis (Hoboken). 2022 Dec 11;20(Suppl 1):45-56. doi: 10.1002/cld.1267. eCollection 2022 Nov.
引用本文的文献
1
A history of the treatment of primary liver cancer.原发性肝癌的治疗史。
Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0147. doi: 10.1097/CLD.0000000000000147. eCollection 2024 Jan-Jun.
本文引用的文献
1
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
2
Reflections on the History of HCV: A Posthumous Examination.丙型肝炎病毒史的反思：一次死后剖析
Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S64-S71. doi: 10.1002/cld.882. eCollection 2020 Feb.
3
TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis.经颈静脉肝内门体分流术与肝硬化患者发生肝细胞癌的较高风险无关：一项系统评价和荟萃分析。
J Clin Transl Hepatol. 2019 Sep 28;7(3):232-237. doi: 10.14218/JCTH.2019.00007. Epub 2019 Jun 14.
4
The Epidemiology of Hepatocellular Carcinoma in the USA.美国肝细胞癌的流行病学
Curr Gastroenterol Rep. 2019 Apr 11;21(4):17. doi: 10.1007/s11894-019-0681-x.
5
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝细胞癌风险。
Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.
6
Should Patients With NAFLD/NASH Be Surveyed for HCC?非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者应筛查肝细胞癌吗？
Transplantation. 2019 Jan;103(1):39-44. doi: 10.1097/TP.0000000000002361.
7
Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.纤维板层肝细胞癌：分子机制的最新进展和未解决的问题。
Semin Liver Dis. 2018 Feb;38(1):51-59. doi: 10.1055/s-0037-1621710. Epub 2018 Feb 22.
8
Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.比斯利1981年的论文：一项设计精良的队列研究对推动肝癌研究与预防的影响力。
Cancer Epidemiol. 2018 Apr;53:195-199. doi: 10.1016/j.canep.2018.01.007. Epub 2018 Feb 13.
9
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.直接作用抗病毒药物诱导的丙型肝炎病毒清除可降低肝细胞癌的风险。
J Hepatol. 2017 Sep 5. doi: 10.1016/j.jhep.2017.08.030.
10
Projections of primary liver cancer to 2030 in 30 countries worldwide.2030 年全球 30 个国家原发性肝癌预测。
Hepatology. 2018 Feb;67(2):600-611. doi: 10.1002/hep.29498. Epub 2017 Dec 23.
Zotero 插件